Figure S1. Coomassie blue staining of the SDS PAGE gels containing the microdissected tissue lysates. (TIF 478 kb
Table S3. List of novel proteins with altered abundances in AD identified in the present study. The ...
Table S3. GO Elite analysis of differentially expressed proteins in WT, LPS-treated WT and 5xFAD mou...
High magnification of an amyloid plaque surrounded by GPNMB-positive microglia. (PDF 481 kb
Figure S2. Total protein fluorescent signal from blots used for immunoblot analysis. Total protein l...
Figure S7. Immunoreactivity for COL6A2 is equally present in leptomeningeal vessels in control, AD a...
Figure S4. Clustering analysis of experimental groups and individual cases. Clustering analysis and ...
Figure S6. Protein expression of males versus females. Quantitative data on several CAA selective da...
Figure S1. SDS-PAGE of Brain Homogenates. Dorsolateral prefrontal cortex (DLPFC) brain tissue homoge...
Table S1. Log2 transformed protein abundance data and differential expression analyses. (XLSX 1522 k...
Table S1. Sample List. AD, Alzheimer’s disease; AS, asymptomatic Alzheimer’s disease; CT, control; M...
Table S2. Case Characteristics. Values shown are means ± SD. AD, Alzheimer’s disease; AsymAD, asympt...
Table S1. Demographic and neuropathological data of human AD patient and control cases. For each cas...
Table S2. GO Elite analysis of all 4,133 proteins identified in mouse microglia by TMT mass spectrom...
Table S4. Pathway analysis of proteins differentially increased in 5xFAD (vs. WT) microglia. (XLSX 1...
Abstract Alzheimer’s disease (AD) is characterized by amyloid beta (Aβ) deposits as plaques in the p...
Table S3. List of novel proteins with altered abundances in AD identified in the present study. The ...
Table S3. GO Elite analysis of differentially expressed proteins in WT, LPS-treated WT and 5xFAD mou...
High magnification of an amyloid plaque surrounded by GPNMB-positive microglia. (PDF 481 kb
Figure S2. Total protein fluorescent signal from blots used for immunoblot analysis. Total protein l...
Figure S7. Immunoreactivity for COL6A2 is equally present in leptomeningeal vessels in control, AD a...
Figure S4. Clustering analysis of experimental groups and individual cases. Clustering analysis and ...
Figure S6. Protein expression of males versus females. Quantitative data on several CAA selective da...
Figure S1. SDS-PAGE of Brain Homogenates. Dorsolateral prefrontal cortex (DLPFC) brain tissue homoge...
Table S1. Log2 transformed protein abundance data and differential expression analyses. (XLSX 1522 k...
Table S1. Sample List. AD, Alzheimer’s disease; AS, asymptomatic Alzheimer’s disease; CT, control; M...
Table S2. Case Characteristics. Values shown are means ± SD. AD, Alzheimer’s disease; AsymAD, asympt...
Table S1. Demographic and neuropathological data of human AD patient and control cases. For each cas...
Table S2. GO Elite analysis of all 4,133 proteins identified in mouse microglia by TMT mass spectrom...
Table S4. Pathway analysis of proteins differentially increased in 5xFAD (vs. WT) microglia. (XLSX 1...
Abstract Alzheimer’s disease (AD) is characterized by amyloid beta (Aβ) deposits as plaques in the p...
Table S3. List of novel proteins with altered abundances in AD identified in the present study. The ...
Table S3. GO Elite analysis of differentially expressed proteins in WT, LPS-treated WT and 5xFAD mou...
High magnification of an amyloid plaque surrounded by GPNMB-positive microglia. (PDF 481 kb